Skip to main content
SpringerLink
Log in
Book cover

Sleep pp 247–255Cite as

Insomnia linked to medications

  • Chapter

  • 701 Accesses

Abstract

For the clinician, insomnia is a symptom which is difficult to understand as it is a predominantly subjective variable: in clinical practice, it is the patient’s complaint which guides the doctor in his diagnostic and therapeutic approach. Insomnia is commonly classified according to different criteria including the time of onset during the night (beginning, middle or end), its course of evolution (occasional, short term or chronic) and the severity of the complaint. The presence of associated signs is a decisive feature in characterising insomnia: it may be isolated or associated with other symptoms. Thus insomnia may evolve in its own right or be part of the framework of a somatic disorder (algic or dyspnoeic, for example) or psychiatric (anxiety disorder, mood disorder, psychose, state of confusion or dementia).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ALBERTS J.L., FRANCOIS F., JOSSERAND F. - Etude des effets secondaires rapportés à l’occasion de traitements par Dogmatil®. Sem. Hôp. Paris, 61, 19, 1351–1357, 1985.

    Google Scholar 

  2. BARRUCAND D., PAILLE F. - Complications neuropsychiatriques de l’alcoolisme . In: Alcoologie, Riom Laboratoires (ed.) CERM, 224–237, 1988.

    Google Scholar 

  3. BASTUJI H., JOUVET M. - Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog. Neuropsychopharmacol. Biol. Psychiatry, 12, 695–700, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. BLACKWELL B., SIMON J.S. - Antidepressant drugs. In: Meyler’s side effects of drugs. M.N.G. Dukes (ed), Elsevier Science Publishers, 11th ed., 27–70, 1988.

    Google Scholar 

  5. BOULANGER J.P., BISSERBE J.C. - Troubles psychiatriques d’origine médicamenteuse, alimentaire ou toxique.Encycl. Med. Chir., Paris, Psychiatrie, 37630 H10, 7, 1983.

    Google Scholar 

  6. BREZINOVA V., ADAM K., CHAPMAN K., OSWALD I., THOMSON J. - Viloxazine, sleep and subjective feelings, Psychopharmacology, 55, 121–128, 1977.

    Article  PubMed  CAS  Google Scholar 

  7. DAMASIO A., LOBO-ANTUNES J., MACEDO C. - Psychiatric aspects in Parkinsonism treated with L-Dopa. J. Neurol. Neurosurg. Psychiatry, 24, 502–507, 1971.

    Article  Google Scholar 

  8. DE GROOT A.C., NATER J.P. - Dermatological drugs and cosmetics. In: Meyler’s side effects of drugs. M.N.G. Dukes (ed.), Elsevier Science Publishers, 11th ed., 284–315, 1988.

    Google Scholar 

  9. DE RECONDO J., ZIEGLER M. - Les antiparkinsoniens In: Neuropharmacologie clinique: le médicament en neurologicH. Dehen., G. Dordain (eds), Doin, Paris, 275–325, 1989.

    Google Scholar 

  10. DOOGAN’ D.P. - Toleration and safety of sertraline: experience worldwide.Int. Clin. Psychopharmacol. 6(suppl.2), 47–56, 1991.

    Article  PubMed  Google Scholar 

  11. ELLINWOOD E.H., ROCKWELL W.J.K. - Central nervous system stimulants and anorectic agents. In: Meyler’s side effects of drugs. M.N.G. Dukes (ed), Elsevier Science Publishers, 11th ed., 1–26, 1988.

    Google Scholar 

  12. ENTSUAH A.R., RUDOLPH R.L., CHITRA R. - Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis. Psychopharmacol Bull, 31, 759–766,1995.

    PubMed  CAS  Google Scholar 

  13. FELINE A., JOUVENT R. - Manifestations psychosensorielles observées chez des psychotiques soumis à des médications ß-mimétiques. Encéphale, 3, 149–158, 1977.

    PubMed  CAS  Google Scholar 

  14. GRAYBILL J.R., CRAVEN P.C. - Antifungal agents used in systemic mycoses activity and therapeutic use. Drugs, 25,41–62, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. HANIN B., MARKS J.- Dépendance aux benzodiazépines et syndrome de sevrage. Revue de la littérature. Psychiatrie et Psychobiologie, 3,347–364, 1988.

    Google Scholar 

  16. HERMANT J.F., RAMBERT F.A., DUTEIL J. - Awakening properties of modafínil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology, 103, 28–32, 1991.

    Article  PubMed  CAS  Google Scholar 

  17. HINDMARCH I., BHATTI J.Z. - Psychopharmacological effects of sertraline in normal healthy volunteers.Eur. J. Clin. Pharmacol. 35: 221–223, 1988.

    Article  PubMed  CAS  Google Scholar 

  18. HINDMARCH I., SHILLINGFORD J., SHILLINGFORD C. - The effects of sertraline in psychomotor performance in elderly volunteers. J. Clin. Psychiatry, 51, 34–36, 1990.

    PubMed  Google Scholar 

  19. IDANPAAN-HEIKKILA J.E., ARANKO K. - Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs, Annual 15, M.N.G. Dukes and J.K. Aronson (ed.), Elsevier Science Publishers. 308–326, 1991.

    Google Scholar 

  20. IMMAN W. - Paroxetine Drug Safety Research Unit, PEM report United Kingdom, 1993.

    Google Scholar 

  21. KARACAN J., THOMBY J.I., ANCH A.M., BOOTH G.H., WILLIAMS R.L., SALIS P.J.- Dose-related sleep disturbances induced by coffee and cafeine. Clin. Pharmacol. Ther., 20, 6, 682–689, 1976.

    PubMed  CAS  Google Scholar 

  22. LADER M. - Fluoxetine efficacy vs comparative drugs: an overview. Br. J. Psychiatry, 3, S51–S58, 1988.

    Google Scholar 

  23. LING M.H., PERRY P.J., MING T.T. - Side effects of corticosteroid therapy. Arch. Gen. Psychiatry, 38, 471–477, 1981.

    Article  PubMed  CAS  Google Scholar 

  24. LOISEAU P., LAROUSSE C., BOURIN M. - Antiépileptiques. Sem. Hôp. Paris60, 39, 2741–2764, 1984.

    CAS  Google Scholar 

  25. LOO H. - Les accidents psychiatriques au cours des thérapeutiques hormonales.Rev. Prat., 25, 2411–2413, 1975.

    PubMed  CAS  Google Scholar 

  26. METZ A., SHADER R.I. - Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine . Intern. Clin. Pharmacol., 5, 191–194, 1990.

    CAS  Google Scholar 

  27. MIGUERES J., JOVER A., GARBARINI A.- Incidents et accidents neuropsychiatriques de la chimiothérapie antituberculeuse. Journal des Agrégés, 3, 111–119, 1970.

    Google Scholar 

  28. PAYKEL E.S., FLEMINGER R., WATSON J.P. - Psychiatric side-effects of antihypertensive drugs other than reserpine. J. Clin. Psychopharmacol., 2, 1, 14–39, 1982.

    Article  PubMed  CAS  Google Scholar 

  29. RICHMAN D.D., FISCHL M.A., GRIECO M.H., GOTTLIEB M.S., VOLBEROING P.A., LASKIN O.L., LEEDOM J.M., GROOPMAN J.E., MILDVAN D., HIRSH M.S. et al. - The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl.J.Med., 192–197,1987.

    Google Scholar 

  30. RICKELS K., WARD T.S., GAUDIN V. - Comparison of two regimens of fluoxetine in major depression. J. Clin. Psychiatry, 46, 3, 38–41, 1985.

    PubMed  CAS  Google Scholar 

  31. SIMON P., CHERMAT R. - Insomnie imputable à l’acide oxolinique. La nouvelle Presse Médicale, 6, 40, 3754, 1977.

    PubMed  Google Scholar 

  32. SMITH J.M. - Abuse of the antiparkinson drugs: a review of the literature. J. Clin. Psychiatry, 41, 351–354, 1980.

    PubMed  CAS  Google Scholar 

  33. VANELLE J.M., AUBIN F., MICHEL F. - Les complications psychiatriques de la corticothérapie. Revue du Praticien, Paris. 16, 556–558, 1990.

    Google Scholar 

  34. VAN RIEL P.L.C.M. - Metals. In: Meyler’s side effects of drugs. M.N.G. Dukes (ed.), Elsevier Science Publisher. 11th ed., 437–460, 1988.

    Google Scholar 

  35. VERSIANI M., OGGERO U., ALTERWAIN P., CAPPONI R., DAJAS F., HEINZE-MARTIN G., MARQUEZ C.A., POLEO M.A., RIVERO-ALMANZOR L.E., ROSSEL L., et al. - A double-blind comparative trial of moclobemide versus imipramine and placebo in major depressive episodes. Br. J. Psychiatry, 155 (suppl. 6), 72–77, 1989.

    Google Scholar 

  36. WAGNER W., CIMANDER K. et al. Influence of concomitant psychotropic medication on the efficacy and tolerance of fluvoxamine. Adv. Pharmacother. 2, 34–56, 1986.

    Google Scholar 

  37. WEISS B., LATIES V.G. - Enhancement of human performance by caffeine and the amphetamines. Pharmacol. Rev., 14, 1, 1–36, 1962.

    PubMed  CAS  Google Scholar 

  38. WENDER P.H. - Pharmacotherapy of attention-deficit / hyperactivity disorders in adults. J. Clin Psychiatry, 59, 76–79, 1998.

    Article  PubMed  Google Scholar 

  39. ZERBE R. - Safety of fluoxetine.Br. J. Clin. Pract., 40, 7 (suppl. 46), 41–47, 1986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Psychiatrie, Centre Hospitalier Universitaire Bicêtre, Le Kremin Bicêtre, France

    E. Corruble

  2. Service de Pharmacologie, Hôpital Pitié-Salpêtrière, Paris, France

    D. Warot & Cl. Soubrie

Authors
  1. E. Corruble
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Warot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cl. Soubrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Gui de Chauliac, Montpellier, France

    Michel Billiard

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Corruble, E., Warot, D., Soubrie, C. (2003). Insomnia linked to medications. In: Billiard, M. (eds) Sleep. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0217-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0217-3_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4970-9

  • Online ISBN: 978-1-4615-0217-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation